Ault Alliance Soars On Financial Status; AVROBIO Climbs On Strategic Leap
- July 12th, 2023
- 344 views
Shares of Ault Alliance, Inc. (NYSE American: AULT) surged over 100% in pre-market trading after the company provided a business update highlighting its financial status.
With approximately 2.1 million shares outstanding and a book value of around $80 per share, the company reported total assets of $527 million. Ault Alliance projects robust financial growth, aiming for $200 million in annual revenue for 2023.
Ault Alliance acknowledges that revenue estimates and projections are influenced by Bitcoin market price volatility, mining difficulty fluctuations, and other operational factors. The company's trading activities, which involve unrealized gains and losses from market price changes, can contribute to notable fluctuations in its periodic earnings.
In pre-market, $AULT is currently trading at $6.90, reflecting an increase of $3.60 (+109.09%)
In other news, AVROBIO, Inc. (Nasdaq: AVRO) has announced a significant decision regarding the future of its programs.
After conducting a thorough review of its business, resources, and capabilities, the company has chosen to halt further development of its programs. Instead, AVROBIO will focus on exploring various strategic alternatives aimed at maximizing shareholder value. These alternatives may include acquisitions, mergers, business combinations, or other transactions.
It is important to note that the exploration process does not guarantee the pursuit or completion of any transaction, and there is no predetermined timeline for its completion
$AVRO is currently trading at $1.27 in pre-market, up $0.29 (+29.63%) following the announcement.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
December 05th, 2025
FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity
December 04th, 2025December 02nd, 2025Earnings Countdown: Salesforce, Snowflake, and Guidewire Take Center Stage
November 30th, 2025Wall Street Eyes CrowdStrike, Marvell Technology, and GitLab as Earnings Near
November 30th, 2025




Member Login